| Financial Year |
March 31 2023 |
| Monetary Funds |
1,205,773,057.43 |
| Held-for-trading Financial Assets |
1,222,489,843.21 |
| Notes Receivable |
2,503,795.59 |
| Accounts Receivable |
982,701,293.84 |
| Advances to Suppliers |
13,256,398.24 |
| Other Receivables |
8,349,476.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
471,953,866.10 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,203,115,492.74 |
| Total Current Assets |
5,238,477,109.65 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
38,301,186.70 |
| Investment Properties |
-- |
| Fixed Assetes |
854,843,061.38 |
| Under-construction Projects |
283,991,825.35 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
133,216,568.98 |
| R&D expenses |
-- |
| Goodwill |
60,712,419.92 |
| Long-Term Deferred and Prepaid Expenses |
34,986,722.18 |
| Deferred Income Tax Assets |
110,808,151.28 |
| Other Non-Current Assets |
27,821,589.44 |
| Sub-Total of Non-Current Assets |
1,596,502,726.82 |
| Total Assets |
6,834,979,836.47 |
| Short-Term Loans |
124,055,111.12 |
| Trading Financial liabilities |
-- |
| Notes Payable |
994,122,814.04 |
| Accounts Payable |
709,892,591.49 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
51,181,934.19 |
| Taxes Payable |
51,988,293.88 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
27,623,840.58 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
16,396,404.23 |
| Other Current Liabilities |
1,156,648.43 |
| Sub-Total of Current Liabilities |
2,015,020,870.61 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
8,056,868.57 |
| Deferred Income Tax Liabilities |
74,226,328.06 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
207,754,420.41 |
| Total Liabilities |
2,222,775,291.02 |
| Paid-In Capital(Or Share Stock) |
276,040,000.00 |
| Capital Surplus |
2,835,355,023.75 |
| Surplus Reserve |
51,192,324.61 |
| LESS:Treasury Stock |
98,664,478.31 |
| Undistributed Profits |
1,507,207,491.27 |
| Minority Stockholder's Interest |
57,218,005.85 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,554,986,539.60 |
| Owner's Equity（Stockholder's Equity） |
4,612,204,545.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,834,979,836.47 |
